Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 10, Pages 3070
Publisher
MDPI AG
Online
2018-10-08
DOI
10.3390/ijms19103070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of the signaling pathway of syndecan-1 by synstatin: A promising anti-integrin inhibitor of angiogenesis and proliferation in HCC in rats
- (2018) Heba A. Metwaly et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Prognostic significance of glypican-3 expression in hepatocellular carcinoma
- (2018) Hong Liu et al. MEDICINE
- Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma
- (2018) Jian Zhang et al. MEDICINE
- Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'
- (2018) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
- (2018) Serena Pellegatta et al. Science Translational Medicine
- Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response
- (2018) Qingyu Xu et al. Oncology Letters
- Elevated GPC3 level promotes cell proliferation in liver cancer
- (2018) Shanshan Wang et al. Oncology Letters
- Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
- (2018) Zeyan Pan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Agrin para-secreted by PDGF-activated human hepatic stellate cells promotes hepatocarcinogenesis in vitro and in vivo
- (2017) Xing Lv et al. Oncotarget
- SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
- (2017) Z Zhang et al. Oncogenesis
- Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma
- (2016) Cheng Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Versican: a novel modulator of hepatic fibrosis
- (2016) Terence N Bukong et al. LABORATORY INVESTIGATION
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner
- (2016) J-Y Guo et al. ONCOGENE
- Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis
- (2016) Qiaoqiao Chu et al. Cell Death & Disease
- Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
- (2016) Ahmed Omar Kaseb et al. Oncotarget
- Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop
- (2016) Ye Zeng et al. Oncotarget
- Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression
- (2016) Y Tanaka et al. Oncogenesis
- Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
- (2016) Yu Sawada et al. OncoImmunology
- Obama's Precision Medicine Initiative
- (2015) Sharon F. Terry Genetic Testing and Molecular Biomarkers
- Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway
- (2015) YONGLE WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma
- (2015) Wael Naboulsi et al. JOURNAL OF PROTEOME RESEARCH
- Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
- (2015) Renato V. Iozzo et al. MATRIX BIOLOGY
- Inhibitory Effect of Endostar on Specific Angiogenesis Induced by Human Hepatocellular Carcinoma
- (2015) Qing Ye et al. Gastroenterology Research and Practice
- An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma
- (2015) Sayan Chakraborty et al. Nature Communications
- Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines
- (2015) Angeliki Korpetinou et al. Biomed Research International
- Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis
- (2014) Xiaobo Jia et al. ARCHIVES OF MEDICAL RESEARCH
- Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
- (2014) Masafumi Ikeda et al. CANCER SCIENCE
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: Preclinical study using mice
- (2014) Yutaka Motomura et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling
- (2014) M. Capurro et al. JOURNAL OF CELL SCIENCE
- Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis
- (2014) Jian He WORLD JOURNAL OF GASTROENTEROLOGY
- Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
- (2013) J.-C. Nault et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- The heparanase/syndecan-1 axis in cancer: mechanisms and therapies
- (2013) Vishnu C. Ramani et al. FEBS Journal
- Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis
- (2013) Alan C. Rapraeger FEBS Journal
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
- (2013) Virginia Hernandez–Gea et al. GASTROENTEROLOGY
- Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression
- (2013) Limin Xia et al. HEPATOLOGY
- Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy
- (2013) I-Pei Chen et al. JOURNAL OF GASTROENTEROLOGY
- Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugs
- (2013) Floriane Pez et al. JOURNAL OF HEPATOLOGY
- Decorin deficiency promotes hepatic carcinogenesis
- (2013) Zsolt Horváth et al. MATRIX BIOLOGY
- Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
- (2013) Lu He et al. MEDICAL ONCOLOGY
- Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
- (2013) Shun-Jun Fu et al. SURGERY
- Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancer
- (2013) Yan Sun et al. Thoracic Cancer
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- Versican 3′-untranslated region (3′-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity
- (2012) Ling Fang et al. FASEB JOURNAL
- Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation
- (2012) Yu-Liang Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
- (2011) Shuichiro Shiina et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma
- (2011) Meiyan Bao et al. LIVER INTERNATIONAL
- Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients
- (2011) Su Ning et al. MOLECULAR BIOLOGY REPORTS
- Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
- (2010) Achilleas D. Theocharis et al. FEBS Journal
- Repression of Versican Expression by MicroRNA-143
- (2010) Xiaobo Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quantitative and Qualitative Alterations of Heparan Sulfate in Fibrogenic Liver Diseases and Hepatocellular Cancer
- (2010) Péter Tátrai et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice
- (2010) Kornélia Baghy et al. LABORATORY INVESTIGATION
- Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C
- (2010) Isabel Zvibel et al. LIVER INTERNATIONAL
- The multiple functions of collagen XVIII in development and disease
- (2010) Lotta Seppinen et al. MATRIX BIOLOGY
- Newly identified tumor-associated role of human Sharpin
- (2010) Jinyoung Jung et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Expression of Versican 3′-Untranslated Region Modulates Endogenous MicroRNA Functions
- (2010) Daniel Y. Lee et al. PLoS One
- Heparanase and hepatocellular carcinoma: Promoter or inhibitor?
- (2010) Shuo Dong WORLD JOURNAL OF GASTROENTEROLOGY
- Agrin and CD34 Immunohistochemistry for the Discrimination of Benign Versus Malignant Hepatocellular Lesions
- (2009) Péter Tátrai et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Serglycin proteoglycan: Regulating the storage and activities of hematopoietic proteases
- (2009) Gunnar Pejler et al. BIOFACTORS
- The biological role and regulation of versican levels in cancer
- (2009) Carmela Ricciardelli et al. CANCER AND METASTASIS REVIEWS
- Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
- (2009) Hirofumi Shirakawa et al. CANCER SCIENCE
- Structure and Regulation of the Versican Promoter
- (2009) Clelia Domenzain-Reyna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Syndecan-1 regulates αvβ3and αvβ5integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor
- (2009) DeannaLee M. Beauvais et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
- Syndecans Shed Their Reputation as Inert Molecules
- (2009) M. D. Bass et al. Science Signaling
- Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
- (2008) Kiyotaka Nakano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface
- (2008) Alexandra Traister et al. BIOCHEMICAL JOURNAL
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway
- (2008) Wei Cheng et al. CARCINOGENESIS
- Glypican-3 Inhibits Hedgehog Signaling during Development by Competing with Patched for Hedgehog Binding
- (2008) Mariana I. Capurro et al. DEVELOPMENTAL CELL
- The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
- (2008) Luca Di Tommaso et al. JOURNAL OF HEPATOLOGY
- microRNA-138 modulates cardiac patterning during embryonic development
- (2008) S. U. Morton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started